Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


An Extremely Premature Newborn with Cutaneous Lesions.

Olivero RM, Caulfield AJ, Fulton BK.

Neoreviews. 2019 Dec;20(12):e757-e760. doi: 10.1542/neo.20-12-e757. No abstract available.


Evaluation of 4 molecular assays as part of a 2-step algorithm for the detection of Clostridium difficile in stool specimens.

Caulfield AJ, Bolster LaSalle CM, Chang YH, Grys TE.

Diagn Microbiol Infect Dis. 2018 May;91(1):1-5. doi: 10.1016/j.diagmicrobio.2017.12.018. Epub 2018 Jan 3.


Proteolysis of plasminogen activator inhibitor-1 by Yersinia pestis remodulates the host environment to promote virulence.

Eddy JL, Schroeder JA, Zimbler DL, Caulfield AJ, Lathem WW.

J Thromb Haemost. 2016 Sep;14(9):1833-43. doi: 10.1111/jth.13408. Epub 2016 Aug 19.


Diagnosis of active tuberculosis disease: From microscopy to molecular techniques.

Caulfield AJ, Wengenack NL.

J Clin Tuberc Other Mycobact Dis. 2016 May 25;4:33-43. doi: 10.1016/j.jctube.2016.05.005. eCollection 2016 Aug. Review.


Lyme Disease Coinfections in the United States.

Caulfield AJ, Pritt BS.

Clin Lab Med. 2015 Dec;35(4):827-46. doi: 10.1016/j.cll.2015.07.006. Epub 2015 Sep 1. Review.


Production of outer membrane vesicles by the plague pathogen Yersinia pestis.

Eddy JL, Gielda LM, Caulfield AJ, Rangel SM, Lathem WW.

PLoS One. 2014 Sep 8;9(9):e107002. doi: 10.1371/journal.pone.0107002. eCollection 2014.


Disruption of fas-fas ligand signaling, apoptosis, and innate immunity by bacterial pathogens.

Caulfield AJ, Lathem WW.

PLoS Pathog. 2014 Aug 7;10(8):e1004252. doi: 10.1371/journal.ppat.1004252. eCollection 2014 Aug. Review. No abstract available.


The Pla protease of Yersinia pestis degrades fas ligand to manipulate host cell death and inflammation.

Caulfield AJ, Walker ME, Gielda LM, Lathem WW.

Cell Host Microbe. 2014 Apr 9;15(4):424-34. doi: 10.1016/j.chom.2014.03.005.


Genome-wide analysis of small RNAs expressed by Yersinia pestis identifies a regulator of the Yop-Ysc type III secretion system.

Schiano CA, Koo JT, Schipma MJ, Caulfield AJ, Jafari N, Lathem WW.

J Bacteriol. 2014 May;196(9):1659-70. doi: 10.1128/JB.01456-13. Epub 2014 Feb 14.


Posttranscriptional regulation of the Yersinia pestis cyclic AMP receptor protein Crp and impact on virulence.

Lathem WW, Schroeder JA, Bellows LE, Ritzert JT, Koo JT, Price PA, Caulfield AJ, Goldman WE.

mBio. 2014 Feb 11;5(1):e01038-13. doi: 10.1128/mBio.01038-13.


RfaL is required for Yersinia pestis type III secretion and virulence.

Houppert AS, Bohman L, Merritt PM, Cole CB, Caulfield AJ, Lathem WW, Marketon MM.

Infect Immun. 2013 Apr;81(4):1186-97. doi: 10.1128/IAI.01417-12. Epub 2013 Jan 28.


Substrates of the plasminogen activator protease of Yersinia pestis.

Caulfield AJ, Lathem WW.

Adv Exp Med Biol. 2012;954:253-60. doi: 10.1007/978-1-4614-3561-7_32. Review. No abstract available.

Supplemental Content

Loading ...
Support Center